FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024562640> ?p ?o ?g. }

• W3024562640 endingPage "1010" @default.
• W3024562640 startingPage "998" @default.
• W3024562640 abstract "Radioembolization (yttrium-90 [Y90]) is used in hepatocellular carcinoma (HCC) as a bridging as well as downstaging liver-directed therapy to curative liver transplantation (LT). In this study, we report long-term outcomes of LT for patients with HCC who were bridged/downstaged by Y90.Patients undergoing LT following Y90 between 2004 and 2018 were included, with staging by United Network for Organ Sharing (UNOS) tumor-node-metastasis criteria at baseline pre-Y90 and pre-LT. Post-Y90 toxicities were recorded. Histopathological data of HCC at explant were recorded. Long-term outcomes, including overall survival (OS), recurrence-free survival (RFS), disease-specific mortality (DSM), and time-to-recurrence, were reported. Time-to-endpoint analyses were estimated using Kaplan-Meier. Univariate and multivariate analyses were performed using a log-rank test and Cox proportional-hazards model, respectively. During the 15-year period, 207 patients underwent LT after Y90. OS from LT was 12.5 years, with a median time to LT of 7.5 months [interquartile range, 4.4-10.3]. A total of 169 patients were bridged, whereas 38 were downstaged to LT. Respectively, 94 (45%), 60 (29%), and 53 (26%) patients showed complete, extensive, and partial tumor necrosis on histopathology. Three-year, 5-year, and 10-year OS rates were 84%, 77%, and 60%, respectively. Twenty-four patients developed recurrence, with a median RFS of 120 (95% confidence interval, 69-150) months. DSM at 3, 5, and 10 years was 6%, 11%, and 16%, respectively. There were no differences in OS/RFS for patients who were bridged or downstaged. RFS was higher in patients with complete/extensive versus partial tumor necrosis (P < 0.0001). For patients with UNOS T2 treated during the study period, 5.2% dropped out because of disease progression.Y90 is an effective treatment for HCC in the setting of bridging/downstaging to LT. Patients who achieved extensive or complete necrosis had better RFS, supporting the practice of neoadjuvant treatment before LT." @default.
• W3024562640 created "2020-05-21" @default.
• W3024562640 creator A5001720875 @default.
• W3024562640 creator A5008135666 @default.
• W3024562640 creator A5009973828 @default.
• W3024562640 creator A5011003738 @default.
• W3024562640 creator A5011256228 @default.
• W3024562640 creator A5027870932 @default.
• W3024562640 creator A5028231848 @default.
• W3024562640 creator A5030361802 @default.
• W3024562640 creator A5033464248 @default.
• W3024562640 creator A5038065771 @default.
• W3024562640 creator A5040236972 @default.
• W3024562640 creator A5044862107 @default.
• W3024562640 creator A5045159543 @default.
• W3024562640 creator A5060796651 @default.
• W3024562640 creator A5064049623 @default.
• W3024562640 creator A5066524469 @default.
• W3024562640 creator A5073412832 @default.
• W3024562640 creator A5075153200 @default.
• W3024562640 creator A5085978876 @default.
• W3024562640 creator A5087536545 @default.
• W3024562640 creator A5090043054 @default.
• W3024562640 date "2020-11-07" @default.
• W3024562640 modified "2023-10-12" @default.
• W3024562640 title "Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐Year Experience in 207‐Patient Cohort" @default.
• W3024562640 cites W1570173114 @default.
• W3024562640 cites W1971211622 @default.
• W3024562640 cites W1973076899 @default.
• W3024562640 cites W1977415173 @default.
• W3024562640 cites W1982200516 @default.
• W3024562640 cites W1992131464 @default.
• W3024562640 cites W1998417832 @default.
• W3024562640 cites W2008655007 @default.
• W3024562640 cites W2020215421 @default.
• W3024562640 cites W2020329640 @default.
• W3024562640 cites W2034342132 @default.
• W3024562640 cites W2045078755 @default.
• W3024562640 cites W2075537728 @default.
• W3024562640 cites W2077014377 @default.
• W3024562640 cites W2086776840 @default.
• W3024562640 cites W2086936353 @default.
• W3024562640 cites W2128125049 @default.
• W3024562640 cites W2140631690 @default.
• W3024562640 cites W2141281005 @default.
• W3024562640 cites W2148287035 @default.
• W3024562640 cites W2153935627 @default.
• W3024562640 cites W2157613091 @default.
• W3024562640 cites W2315027248 @default.
• W3024562640 cites W2509930573 @default.
• W3024562640 cites W2526949245 @default.
• W3024562640 cites W2528356436 @default.
• W3024562640 cites W2585397630 @default.
• W3024562640 cites W2730456895 @default.
• W3024562640 cites W2746343077 @default.
• W3024562640 cites W2772445760 @default.
• W3024562640 cites W2946536920 @default.
• W3024562640 cites W4245784696 @default.
• W3024562640 doi "https://doi.org/10.1002/hep.31318" @default.
• W3024562640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32416631" @default.
• W3024562640 hasPublicationYear "2020" @default.
• W3024562640 type Work @default.
• W3024562640 sameAs 3024562640 @default.
• W3024562640 citedByCount "53" @default.
• W3024562640 countsByYear W30245626402020 @default.
• W3024562640 countsByYear W30245626402021 @default.
• W3024562640 countsByYear W30245626402022 @default.
• W3024562640 countsByYear W30245626402023 @default.
• W3024562640 crossrefType "journal-article" @default.
• W3024562640 hasAuthorship W3024562640A5001720875 @default.
• W3024562640 hasAuthorship W3024562640A5008135666 @default.
• W3024562640 hasAuthorship W3024562640A5009973828 @default.
• W3024562640 hasAuthorship W3024562640A5011003738 @default.
• W3024562640 hasAuthorship W3024562640A5011256228 @default.
• W3024562640 hasAuthorship W3024562640A5027870932 @default.
• W3024562640 hasAuthorship W3024562640A5028231848 @default.
• W3024562640 hasAuthorship W3024562640A5030361802 @default.
• W3024562640 hasAuthorship W3024562640A5033464248 @default.
• W3024562640 hasAuthorship W3024562640A5038065771 @default.
• W3024562640 hasAuthorship W3024562640A5040236972 @default.
• W3024562640 hasAuthorship W3024562640A5044862107 @default.
• W3024562640 hasAuthorship W3024562640A5045159543 @default.
• W3024562640 hasAuthorship W3024562640A5060796651 @default.
• W3024562640 hasAuthorship W3024562640A5064049623 @default.
• W3024562640 hasAuthorship W3024562640A5066524469 @default.
• W3024562640 hasAuthorship W3024562640A5073412832 @default.
• W3024562640 hasAuthorship W3024562640A5075153200 @default.
• W3024562640 hasAuthorship W3024562640A5085978876 @default.
• W3024562640 hasAuthorship W3024562640A5087536545 @default.
• W3024562640 hasAuthorship W3024562640A5090043054 @default.
• W3024562640 hasConcept C119060515 @default.
• W3024562640 hasConcept C126322002 @default.
• W3024562640 hasConcept C141071460 @default.
• W3024562640 hasConcept C203092338 @default.
• W3024562640 hasConcept C2778019345 @default.
• W3024562640 hasConcept C2779609443 @default.
• W3024562640 hasConcept C2911091166 @default.
• W3024562640 hasConcept C50382708 @default.

• next